LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer

Detalles Bibliográficos
Autores principales: Zhou, Jialin, Feng, Chun, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326162/
https://www.ncbi.nlm.nih.gov/pubmed/35912168
http://dx.doi.org/10.3389/fonc.2022.911572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326162/
https://www.ncbi.nlm.nih.gov/pubmed/35912168
http://dx.doi.org/10.3389/fonc.2022.911572

Ejemplares similares